New Concerns Over Maternity Safety and Women's Health Guidance

A significant disagreement has emerged following the publication of a major government-ordered review into maternity safety in England. Dr. Bill Kirkup, a former member of the investigation team, resigned from his position after claiming that important criticism was removed from the report just days before it was released. According to the BBC, the removed section focused on the 'normal birth drive,' a policy that encourages vaginal delivery without medical interventions like pain relief or surgery.

This approach, which was promoted by the Royal College of Midwives for many years, has been criticized in several previous reviews. Critics argue that the push for 'natural' birth at any cost has led to avoidable deaths and harm for mothers and babies. Dr. Kirkup, who has led previous inquiries into maternity safety, stated that evidence of this issue was found during the investigation. He told the BBC that he felt it was necessary to 'shine a light' on the problem to ensure patient safety, but he believes the final report failed to do so.

In response to these claims, Baroness Amos, who led the investigation, told the BBC that the 'normal birth' ideology did not emerge as a key theme during her team's work. She noted that while some families mentioned feeling pressured toward natural birth, it was not a dominant finding. The final report, published on Tuesday, focuses on the fact that women are frequently not listened to by maternity staff. The government has already accepted a key recommendation from the report to appoint a maternity commissioner to oversee improvements in the system.

While the maternity sector faces these difficult questions, the NHS is also working to improve care in other areas of women's health. The National Institute for Health and Care Excellence (Nice) has published new draft guidance regarding polyendocrine metabolic ovarian syndrome, or PMOS. This condition, formerly known as polycystic ovarian syndrome, is estimated to affect up to 13% of women of reproductive age. According to The Guardian, the condition is often underdiagnosed and inconsistently managed, despite affecting millions of people in the UK.

PMOS can cause irregular periods, excess levels of testosterone, and other physical symptoms. It is also linked to a higher risk of serious long-term health issues, including type 2 diabetes, heart disease, and mental health challenges. The new draft guidance suggests that healthcare professionals should offer blood tests and, in some cases, ultrasounds to women and girls who show signs of the condition. The guidance also emphasizes that doctors should consider the higher prevalence of PMOS among black, Asian, and mixed-ethnicity women when assessing symptoms.

Marieanne Ledingham, a consultant at Nice, explained that the new guidelines are an important step toward ensuring patients receive the ongoing care they need. The proposal recommends an annual review for those diagnosed with PMOS to monitor their symptoms and discuss risks related to diabetes, obesity, and cardiovascular health. Dr. Rachel Reid-McCann, a researcher at Oxford University, told The Guardian that a formal diagnosis is important because it opens access to support and advice that can help reduce long-term health risks.

However, the implementation of these guidelines may face challenges. The Guardian reports that the key difficulty will be ensuring that NHS services have the necessary resources to provide this level of monitoring. Additionally, the draft guidance clarifies that certain cosmetic treatments, such as laser hair removal, will not be offered by the NHS because they are not considered cost-effective ways to improve general health. The consultation period for these new guidelines is open until August 11, 2026, with the final version expected in December.

These two developments reflect a broader push to reform and standardize care for women in England. Whether it is addressing the culture of maternity units or improving the diagnosis of common hormonal conditions, the focus remains on listening to patients and providing consistent, evidence-based support. As the government moves forward with the appointment of a maternity commissioner and the review of the PMOS guidelines, the goal is to prevent future harm and ensure that all patients receive the attention they deserve.